Related Experiment Video
Updated: Mar 21, 2026

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
Massive intravenous manganese overdose due to compounding error: minimal role for hemodialysis
Elizabeth Quaal Hines1,2, Irfana Soomro3, Mary Ann Howland1,2,4
1a Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine , NYU School of Medicine , New York , NY , USA ;
Context:
Manganese-associated parkinsonism is well described in occupational settings, in chronic methcathinone users, and in patients receiving long-term total parenteral nutrition. We present a unique case of acute intravenous manganese poisoning with a systematic evaluation of hemodialysis efficacy.
Case Details:
A 52-year-old woman was inadvertently administered a single intravenous dose of 800 mg compounded manganese chloride at an outpatient chelation center. In an attempt to minimize central nervous system (CNS) manganese deposition, she underwent urgent hemodialysis followed by five days of therapy with calcium disodium EDTA (1 g/m(2) over eight hours daily). Her initial whole blood manganese concentration, obtained six hours after exposure and prior to treatment, was 120 mcg/L (2.19 micromol/L); normal <5 mcg/L (< 0.09 micromol/L). Following the first four-hour hemodialysis session her blood manganese concentration decreased to 20 mcg/L (0.36 micromol/L). Despite the fall in her blood manganese concentration, analysis of dialysate revealed a total elimination of only 604 mcg (11 micromol) manganese (∼1.4% of manganese burden). Although she remained asymptomatic, an MRI on hospital day two revealed T1 hyperintensities within the bilateral globus pallidi, consistent with manganese exposure.
Discussion:
Manganese poisoning is associated with irreversible neurologic toxicity. Hemodialysis did not appear to significantly enhance elimination in this case of acute intravenous manganese toxicity, beyond supportive care and calcium disodium EDTA chelation.
Insights
Acute manganese poisoning can cause irreversible neurological damage. Hemodialysis showed limited effectiveness in enhancing manganese elimination in this case, highlighting the importance of chelation therapy.
Area of Science:
- Neurology
- Toxicology
- Nephrology
Background:
- Manganese-associated parkinsonism is recognized in occupational settings, methcathinone users, and patients on long-term parenteral nutrition.
- This study details a unique case of acute intravenous manganese poisoning.
Observation:
- A 52-year-old woman received an 800 mg intravenous dose of manganese chloride.
- She underwent hemodialysis and calcium disodium EDTA chelation therapy.
- Initial blood manganese was 120 mcg/L, decreasing to 20 mcg/L post-hemodialysis, with minimal manganese elimination via dialysis.
Findings:
- Hemodialysis removed only approximately 1.4% of the total manganese burden.
- Despite reduced blood manganese levels, MRI revealed T1 hyperintensities in the globus pallidi, indicative of manganese exposure.
- Manganese poisoning is linked to irreversible neurological toxicity.
Implications:
- Hemodialysis may not significantly enhance manganese elimination in acute poisoning.
- Chelation therapy remains a crucial component of supportive care.
- This case underscores the potential for severe neurological consequences from acute manganese overexposure.
More Related Videos
08:36Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
08:51Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
Published on: November 11, 2022
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Drug Toxicity: Dose-Dependent Reactions
Prevention of Further Absorption of Poison
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Toxicity: Overview